Thrombotic and Atherogenetic Predisposition in Polyglobulic Donors.
JAK2
mutation
polycythemia vera
secondary polyglobulia
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
12 Apr 2022
12 Apr 2022
Historique:
received:
09
02
2022
revised:
31
03
2022
accepted:
07
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
This work analyses the results of research regarding the predisposition of genetic hematological risks associated with secondary polyglobulia. The subjects of the study were selected based on shared laboratory markers and basic clinical symptoms.
Identifiants
pubmed: 35453637
pii: biomedicines10040888
doi: 10.3390/biomedicines10040888
pmc: PMC9027744
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nature. 2005 Apr 28;434(7037):1144-8
pubmed: 15793561
Ann Hematol. 2008 Dec;87(12):1013-6
pubmed: 18654780
JAMA. 2002 Oct 23-30;288(16):2023-31
pubmed: 12387655
Exp Gerontol. 2008 Aug;43(8):801-5
pubmed: 18504081
Pathology. 2019 Feb;51(2):165-176
pubmed: 30598326
Blood Rev. 2020 Jul;42:100714
pubmed: 32546373
Thromb Res. 1999 Jun 1;94(5):271-305
pubmed: 10379818
J Am Heart Assoc. 2018 Oct 16;7(20):e009778
pubmed: 30371276
Circulation. 1996 Feb 1;93(3):440-9
pubmed: 8565160
Thromb Haemost. 1998 Dec;80(6):956-60
pubmed: 9869167
J Mol Med (Berl). 2016 Jul;94(7):739-46
pubmed: 27277824
J Thromb Haemost. 2005 Feb;3(2):292-9
pubmed: 15670035
Lancet. 2005 Mar 19-25;365(9464):1054-61
pubmed: 15781101
Nitric Oxide. 2001 Apr;5(2):88-97
pubmed: 11292358
Blood. 2007 Aug 15;110(4):1092-7
pubmed: 17488875
Curr Treat Options Oncol. 2018 Mar 7;19(2):12
pubmed: 29516275
Am J Hematol. 2019 Jan;94(1):133-143
pubmed: 30281843
Blood. 2017 Feb 9;129(6):680-692
pubmed: 28028026
J Thromb Haemost. 2018 Sep;16(9):1817-1829
pubmed: 29879294
J Thromb Haemost. 2004 May;2(5):750-3
pubmed: 15099281
Clin Auton Res. 2019 Apr;29(2):231-243
pubmed: 30413906
Thromb Haemost. 2005 Aug;94(2):389-94
pubmed: 16113830
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75
pubmed: 12588755
Nitric Oxide. 2002 Aug;7(1):1-10
pubmed: 12175813
Circulation. 1998 Apr 14;97(14):1411-20
pubmed: 9577953
Intensive Care Med. 1998 Jan;24(1):3-11
pubmed: 9503216
Pharmacol Rep. 2005;57 Suppl:59-65
pubmed: 16415487
Clin Chem. 2003 Mar;49(3):389-95
pubmed: 12600950
Cancer Cell. 2005 Apr;7(4):387-97
pubmed: 15837627
J Natl Compr Canc Netw. 2016 Oct;14(10):1238-1245
pubmed: 27697978
Expert Rev Hematol. 2016 Dec;9(12):1139-1149
pubmed: 27797270
J Biol Chem. 1985 Sep 15;260(20):11107-14
pubmed: 2411729
Blood. 2006 Sep 15;108(6):1865-7
pubmed: 16728702
J Clin Invest. 1984 Nov;74(5):1701-7
pubmed: 6238978
Br J Haematol. 2001 Nov;115(2):354-9
pubmed: 11703335
Genet Med. 2011 Jan;13(1):1-16
pubmed: 21116184
JAMA Cardiol. 2019 Dec 1;4(12):1287-1295
pubmed: 31642874
Methods Mol Biol. 2017;1646:113-135
pubmed: 28804823
Exp Eye Res. 2019 Sep;186:107680
pubmed: 31129252
Haematologica. 2007 Jan;92(1):135-6
pubmed: 17229651
Blood. 2017 Feb 9;129(6):667-679
pubmed: 28028029
Blood. 2008 Feb 1;111(3):1686-9
pubmed: 17984312
Expert Opin Ther Targets. 2020 Jul;24(7):615-628
pubmed: 32366208
Curr Opin Genet Dev. 2007 Feb;17(1):8-14
pubmed: 17208428
Blood. 1998 Aug 15;92(4):1119-24
pubmed: 9694698
N Engl J Med. 2005 Apr 28;352(17):1779-90
pubmed: 15858187